04/17/2024
3:53 PM | Tango Therapeutics (Filer)
| Form PRE 14A | |
04/08/2024
7:46 AM | Southpoint Capital Advisors LP (Filed by)
Tango Therapeutics (Subject)
| Form SC 13G/A | |
03/18/2024
7:27 AM | Tango Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/18/2024
6:19 AM | Tango Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/18/2024
6:08 AM | Tango Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/21/2024
4:52 PM | Tango Therapeutics (Issuer)
Third Rock Ventures GP IV, L.P. (Reporting)
Third Rock Ventures IV, L.P. (Reporting)
TRV GP IV, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2024
11:32 AM | Tango Therapeutics (Subject)
Third Rock Ventures IV, L.P. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
|
02/09/2024
8:49 AM | FMR LLC (Filed by)
Tango Therapeutics (Subject)
| Form SC 13G/A | |
02/08/2024
8:04 PM | Crystal Adam (Reporting)
Tango Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/08/2024
8:08 PM | Beckman Daniella (Reporting)
Tango Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/08/2024
8:09 PM | Barry Douglas (Reporting)
Tango Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/08/2024
8:14 PM | Tango Therapeutics (Issuer)
Weber Barbara (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/07/2024
6:00 AM | Tango Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/08/2023
6:29 AM | Tango Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/08/2023
6:07 AM | Tango Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/02/2023
3:49 PM | Crystal Adam (Reporting)
Tango Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/18/2023
4:23 PM | BCTG Holdings, LLC (Filed by)
Tango Therapeutics (Subject)
| Form SC 13D/A | |
10/17/2023
6:41 PM | Boxer Asset Management Inc. (Reporting)
Boxer Capital, LLC (Reporting)
Davis Aaron I. (Reporting)
LEWIS JOSEPH (Reporting)
MVA Investors, LLC (Reporting)
Tango Therapeutics (Issuer)
| Form 4/A | |
10/17/2023
5:04 PM | Boxer Asset Management Inc. (Reporting)
Boxer Capital, LLC (Reporting)
Davis Aaron I. (Reporting)
LEWIS JOSEPH (Reporting)
MVA Investors, LLC (Reporting)
Tango Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/16/2023
2:33 PM | EcoR1 Capital, LLC (Filed by)
Tango Therapeutics (Subject)
| Form SC 13G/A | |
10/16/2023
2:42 PM | EcoR1 Capital, LLC (Reporting)
Tango Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
10/11/2023
8:22 PM | Boxer Asset Management Inc. (Reporting)
Boxer Capital, LLC (Reporting)
Davis Aaron I. (Reporting)
LEWIS JOSEPH (Reporting)
MVA Investors, LLC (Reporting)
Tango Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/11/2023
6:22 PM | Boxer Asset Management Inc. (Reporting)
Boxer Capital, LLC (Reporting)
Davis Aaron I. (Reporting)
LEWIS JOSEPH (Reporting)
MVA Investors, LLC (Reporting)
Tango Therapeutics (Issuer)
| Form 4/A | |
10/10/2023
8:42 PM | MVA Investors, LLC (Reporting)
Tango Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/10/2023
8:43 PM | Boxer Capital, LLC (Reporting)
Tango Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/21/2023
4:16 PM | EcoR1 Capital, LLC (Filed by)
Tango Therapeutics (Subject)
| Form SC 13G | |
09/11/2023
11:15 PM | Tango Therapeutics (Filer)
| Form EFFECT | |
09/11/2023
7:23 AM | FMR LLC (Filed by)
Tango Therapeutics (Subject)
| Form SC 13G/A | |
09/01/2023
6:34 AM | Tango Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
08/30/2023
5:04 AM | Tango Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/24/2023
3:10 PM | Tango Therapeutics (Filer)
| Form D
Notice of Exempt Offering of Securities | |
08/22/2023
3:15 PM | Tango Therapeutics (Issuer)
Third Rock Ventures GP VI, L.P. (Reporting)
Third Rock Ventures VI, L.P. (Reporting)
TRV GP VI, LLC (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/21/2023
3:16 PM | Nextech Crossover I GP S.a r.l. (Filed by)
Tango Therapeutics (Subject)
| Form SC 13G | |
08/16/2023
3:40 PM | BCTG Holdings, LLC (Filed by)
Tango Therapeutics (Subject)
| Form SC 13D/A | |
08/15/2023
8:34 PM | Boxer Asset Management Inc. (Reporting)
Boxer Capital, LLC (Reporting)
Davis Aaron I. (Reporting)
LEWIS JOSEPH (Reporting)
MVA Investors, LLC (Reporting)
Tango Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/10/2023
6:24 AM | Tango Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/07/2023
6:57 AM | Tango Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/07/2023
6:25 AM | Tango Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/08/2023
8:36 PM | Borisy Alexis (Reporting)
Tango Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/08/2023
8:39 PM | Calhoun Lesley Ann (Reporting)
Tango Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/08/2023
8:40 PM | Rothenberg Mace (Reporting)
Tango Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
SHOCKING Crypto Leak… (Ad) A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products.
If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE…
The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.
 Claim your free seat by clicking here now. |
06/08/2023
8:32 PM | Davis Aaron I. (Reporting)
Tango Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/08/2023
8:33 PM | Peters Malte (Reporting)
Tango Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/08/2023
8:34 PM | Huber Reid M (Reporting)
Tango Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2023
3:49 PM | Tango Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/09/2023
6:31 AM | Tango Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/09/2023
6:22 AM | Tango Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/24/2023
3:47 PM | Tango Therapeutics (Filer)
| Form ARS | |
04/24/2023
3:40 PM | Tango Therapeutics (Filer)
| Form DEFA14A | |
04/24/2023
3:31 PM | Tango Therapeutics (Filer)
| Form DEF 14A | |
